Cancer, Hypoxia, and Metabolism

Solid tumors frequently outgrow their blood supply, creating oxygen-starved regions that force cancer cells to rewire how they generate energy and build biomass. A central player in this adaptation is HIF-1, a transcription factor that responds to low oxygen by shifting cells toward glycolysis — even when oxygen is available, a phenomenon known as the Warburg effect — while also coordinating changes in glutamine metabolism and mitochondrial function that sustain rapid cell proliferation. Researchers are working to understand precisely how these metabolic shifts interact with the broader tumor microenvironment and why some cancers depend on specific pathways, such as hexokinase II-driven glycolysis, in ways that healthy tissue does not. A key open question is whether targeting these metabolic vulnerabilities — for instance by inhibiting glycolysis or disrupting oxygen-sensing machinery — can selectively starve tumors without causing unacceptable harm to normal cells that share many of the same pathways.

Works

144,505

Total citations

2,944,215

Keywords

HIF-1Warburg EffectTumor HypoxiaCancer Cell MetabolismGlutamine MetabolismOxygen Sensing